B Bottasso
Overview
Explore the profile of B Bottasso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
328
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Primignani M, DellEra A, Bucciarelli P, Bottasso B, Bajetta M, de Franchis R, et al.
Dig Liver Dis
. 2008 Mar;
40(11):874-81.
PMID: 18329968
Background And Aim: Variceal bleeding carries a high-mortality rate in patients with liver cirrhosis. Since coagulation and fibrinolysis are abnormal in these patients we evaluated whether or not abnormalities of...
2.
Saibeni S, Bottasso B, Spina L, Bajetta M, Danese S, Gasbarrini A, et al.
Am J Gastroenterol
. 2004 Sep;
99(10):1966-70.
PMID: 15447757
Objectives: Hypofibrinolysis has been proposed as a possible mechanism underlying the known risk of thrombosis observed in patients with inflammatory bowel diseases (IBD). Thrombin-activatable fibrinolysis inhibitor (TAFI) is a recently...
3.
Marasini B, Massarotti M, Bottasso B, Coppola R, Del Papa N, Maglione W, et al.
Scand J Rheumatol
. 2004 Sep;
33(4):253-6.
PMID: 15370722
Objective: The prostanoids iloprost and alprostadil are widely used to treat ischaemic changes in patients with Raynaud's phenomenon (RP), but the optimal regimen is poorly defined. We evaluated whether there...
4.
Cugno M, Salerno F, Nussberger J, Bottasso B, Lorenzano E, AGOSTONI A
Clin Sci (Lond)
. 2001 Nov;
101(6):651-7.
PMID: 11724653
Bradykinin, a nonapeptide with vasodilatory and permeabilizing activity, is generated through the cleavage of high-M(r) ('high-molecular-weight') kininogen by kallikrein, and its generation is facilitated by plasmin. In the ascitic fluid...
5.
Gardinali M, Pozzi M, Bernareggi M, Montani N, Allevi E, Catena L, et al.
J Rheumatol
. 2001 May;
28(4):786-94.
PMID: 11327251
Objective: To evaluate the efficacy and safety of prostaglandin (PG) E1alpha-cyclodextrin for Raynaud's phenomenon (RP) secondary to systemic sclerosis (SSc) and its effect on variables of immune activation and endothelial...
6.
Sartorio A, Cattaneo M, Bucciarelli P, Bottasso B, Porretti S, Epaminonda P, et al.
Exp Clin Endocrinol Diabetes
. 2000 Nov;
108(7):486-92.
PMID: 11083070
Alterations of coagulation and fibrinolytic systems might contribute to the increased cardiovascular and cerebrovascular mortality observed in patients with both chronic growth hormone (GH) excess (acromegaly) and deficiency (GHD). However,...
7.
Merlini P, Ardissino D, Rosenberg R, Colombi E, Agricola P, Oltrona L, et al.
Arterioscler Thromb Vasc Biol
. 2000 Sep;
20(9):2162-6.
PMID: 10978264
In patients with unstable angina, intravenous heparin reduces thrombin activity but does not influence thrombin generation. Recombinant hirudin, a direct thrombin inhibitor, may be more effective in inhibiting both thrombin...
8.
Ambrosi B, Sartorio A, Pizzocaro A, Passini E, Bottasso B, Federici A
Exp Clin Endocrinol Diabetes
. 2000 Aug;
108(4):294-8.
PMID: 10961361
It is known that either chronic glucocorticoid administration or endogenous hypercortisolism frequently induce an hypercoagulable condition. Since little is known about the evaluation of markers of haemostatic and fibrinolytic systems...
9.
Fatti L, Bottasso B, Invitti C, Coppola R, Cavagnini F, Mannucci P
J Endocrinol Invest
. 2000 May;
23(3):145-50.
PMID: 10803470
Patients with active Cushing's syndrome have an increased thrombotic tendency. We chose to reassess the mechanism underlying the thrombophilic state associated with this clinical condition using sensitive markers of coagulation...
10.
Bergamaschini L, Canziani S, Bottasso B, Cugno M, Braidotti P, AGOSTONI A
Clin Exp Immunol
. 1999 Apr;
115(3):526-33.
PMID: 10193429
beta-Amyloid (beta-A) accumulates in the brain of patients with Alzheimer's disease (AD) and is presumably involved in the pathogenesis of this disease, on account of its neurotoxicity and complement-activating ability....